The French start-up Resilience has raised a round Serie A of 40 million euros led by Cathay Innovation. The startup aims to improve the treatment process when you are diagnosed with cancer so that you live a healthier and longer life.
In addition to Cathay Innovation, the existing investor Singular is also involved. Other funds join the round, such as Exor Seeds, Picus Capital and Seaya Ventures. Finally, some healthcare investors are completing the round: Fondation Santé Service, MACSF, Ramsay Santé and Vivalto Ventures.
Co-founded by two entrepreneurs, Céline Lazorthes and Jonathan Benhamou, the company wants to help both patients and caregivers when it comes to cancer care.
On the patient's side, Resilience helps you measure, understand, and deal with the effects and side effects of cancer and cancer treatments. Users can track various data points in the app and find content and information about their disease.
However Resilience it's not just an app to use at home. It is also a software-as-a-service solution for hospitals so they can better personalize their treatments. Resilience was founded in collaboration with Gustave Roussy, one of the world's leading cancer research institutes.
Doctors will be able to take advantage of all the data that patients have collected from the application. In this way, cancer treatment centers understand the patient better and can adapt their care more quickly. Resilience search to improve when it comes to data-driven cancer care.
The long-term vision is even more ambitious. Caregivers who work in a cancer treatment center never have enough time.
And it's even harder to keep track of new treatments that are becoming more and more specialized. Resilience does not want to replace doctors. But he wants to help them overcome blind spots.
The result should be better care for patients, as well as more support through the app Resilience. Cancer care is a long and painful process, so anything that can improve this process is a good thing.
